Insiderkauf

Apogee Therapeutics

APGE

Insidertransaktionen und Aktienkurs 2024-2026

Alle Insidertrades bei Apogee Therapeutics

RSS abonnieren
Datum Typ Insider Position Ø-Preis Volumen
5.8.2026 Verkauf Dambkowski, Carl Chief Medical Officer 134,2 $ 737.935 $
8.7.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 133,6 $ 2.672.600 $
1.7.2026 Verkauf Dambkowski, Carl Chief Medical Officer 132,7 $ 730.070 $
22.6.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 132,5 $ 10.603.200 $
22.6.2026 Verkauf Dambkowski, Carl Chief Medical Officer 132,6 $ 3.500.640 $
10.6.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 84,6 $ 1.667.621 $
3.6.2026 Verkauf Dambkowski, Carl Chief Medical Officer 78,7 $ 432.905 $
13.5.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 82,3 $ 1.641.711 $
6.5.2026 Verkauf Dambkowski, Carl Chief Medical Officer 84,3 $ 462.784 $
1.5.2026 Verkauf Henderson, Jane Chief Financial Officer 82,3 $ 164.080 $
16.4.2026 Verkauf Henderson, Jane Chief Financial Officer 90,0 $ 180.000 $
8.4.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 83,6 $ 1.651.664 $
1.4.2026 Verkauf Henderson, Jane Chief Financial Officer 85,0 $ 170.020 $
1.4.2026 Verkauf Dambkowski, Carl Chief Medical Officer 85,2 $ 466.619 $
25.3.2026 Verkauf Henderson, Jane Chief Financial Officer 85,0 $ 170.000 $
11.3.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 75,0 $ 1.495.604 $
4.3.2026 Verkauf Dambkowski, Carl Chief Medical Officer 71,9 $ 390.825 $
2.3.2026 Verkauf Henderson, Jane Chief Financial Officer 70,0 $ 140.431 $
11.2.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 63,9 $ 1.266.952 $
4.2.2026 Verkauf Dambkowski, Carl Chief Medical Officer 66,9 $ 361.860 $
2.2.2026 Verkauf Henderson, Jane Chief Financial Officer 66,1 $ 131.629 $
22.1.2026 Verkauf Fairmount Funds Management LLC Aufsichtsrat 76,3 $ 133.525.000 $
14.1.2026 Verkauf Henderson, Michael Thomas Chief Executive Officer 81,5 $ 1.622.159 $
7.1.2026 Verkauf Dambkowski, Carl Chief Medical Officer 78,5 $ 1.455.613 $
6.1.2026 Verkauf Henderson, Jane Chief Financial Officer 80,0 $ 160.000 $
2.1.2026 Verkauf Henderson, Jane Chief Financial Officer 74,7 $ 449.146 $
19.12.2025 Verkauf Henderson, Jane Chief Financial Officer 80,0 $ 120.000 $
10.12.2025 Verkauf Henderson, Michael Thomas Chief Executive Officer 75,8 $ 1.507.657 $
4.12.2025 Verkauf Henderson, Michael Thomas Chief Executive Officer 75,0 $ 3.000.400 $
4.12.2025 Verkauf Henderson, Jane Chief Financial Officer 75,0 $ 112.500 $
4.12.2025 Verkauf Dambkowski, Carl Chief Medical Officer 75,0 $ 817.500 $
25.11.2025 Verkauf Henderson, Jane Chief Financial Officer 70,0 $ 105.000 $
14.11.2025 Verkauf Henderson, Jane Chief Financial Officer 65,0 $ 130.000 $
13.11.2025 Verkauf Henderson, Michael Thomas Chief Executive Officer 63,4 $ 1.260.236 $
11.11.2025 Verkauf Henderson, Jane Chief Financial Officer 60,0 $ 60.000 $
5.11.2025 Verkauf Dambkowski, Carl Chief Medical Officer 55,1 $ 593.903 $
1.10.2025 Verkauf Dambkowski, Carl Chief Medical Officer 39,8 $ 203.378 $
3.9.2025 Verkauf Dambkowski, Carl Chief Medical Officer 38,2 $ 103.198 $
6.8.2025 Verkauf Dambkowski, Carl Chief Medical Officer 37,8 $ 102.951 $
2.7.2025 Verkauf Dambkowski, Carl Chief Medical Officer 45,5 $ 454.954 $
4.6.2025 Verkauf Dambkowski, Carl Chief Medical Officer 37,0 $ 100.716 $
7.5.2025 Verkauf Dambkowski, Carl Chief Medical Officer 35,8 $ 97.419 $
2.4.2025 Verkauf Dambkowski, Carl Chief Medical Officer 36,7 $ 139.802 $
5.3.2025 Verkauf Henderson, Michael Thomas Chief Executive Officer 30,3 $ 301.511 $
5.3.2025 Verkauf Dambkowski, Carl Chief Medical Officer 30,5 $ 48.463 $
5.2.2025 Verkauf Henderson, Michael Thomas Chief Executive Officer 40,6 $ 608.700 $
5.2.2025 Verkauf Dambkowski, Carl Chief Medical Officer 40,7 $ 143.229 $
8.1.2025 Verkauf Henderson, Michael Thomas Chief Executive Officer 49,0 $ 732.693 $
2.1.2025 Verkauf Dambkowski, Carl Chief Medical Officer 47,2 $ 191.740 $
12.12.2024 Kauf Mckenna, Mark C. Aufsichtsrat 49,4 $ 990.775 $
11.12.2024 Verkauf Dambkowski, Carl Chief Medical Officer 49,3 $ 221.363 $
4.12.2024 Verkauf Henderson, Michael Thomas Chief Executive Officer 46,8 $ 698.654 $
4.12.2024 Verkauf Dambkowski, Carl Chief Medical Officer 46,1 $ 307.057 $
6.11.2024 Verkauf Henderson, Michael Thomas Chief Executive Officer 59,6 $ 888.320 $
6.11.2024 Verkauf Dambkowski, Carl Chief Medical Officer 59,4 $ 394.041 $
2.10.2024 Verkauf Henderson, Michael Thomas Chief Executive Officer 56,4 $ 2.249.307 $
2.10.2024 Verkauf Dambkowski, Carl Chief Medical Officer 56,5 $ 374.954 $
4.9.2024 Verkauf Henderson, Michael Thomas Chief Executive Officer 47,8 $ 1.904.841 $
4.9.2024 Verkauf Dambkowski, Carl Chief Medical Officer 47,8 $ 316.969 $
23.8.2024 Verkauf Henderson, Jane Chief Financial Officer 48,3 $ 289.560 $
Rows per page:
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)